HOME >> BIOLOGY >> NEWS
New drugs for cancer therapy at international conference in Amsterdam

Among the drugs that will be discussed in Amsterdam over the next three days are bevacizumab, cetuximab, dasatinib, erlotinib, lapatinib, nilotinib, oblimersen sodium, sorafenib, and sunitinib. All of these have been approved or are awaiting regulatory approval in various cancer indications. In addition, a range of agents in earlier phases of development will be discussed. The TAT 2007 program incorporates presentations of results from early-phase clinical trials (phase I and phase II) that have not been released before.

Targeted anticancer agents are the subject of extensive research and development activities worldwide, often conducted in joint projects of academic research institutes and pharmaceutical companies. These drugs are characterized by the fact that they have a well-defined molecular target, which is known to play a role in the growth of tumors or the blood vessels supplying the tumor with nutrients.

Many leading cancer institutes from all over the world are represented at the TAT 2007 conference in Amsterdam. In total, about 600 delegates from over 40 countries will gather at the VU University Main Building in a conference organized by the Amsterdam-based NDDO Research Foundation in a partnership with the European Society for Medical Oncology (ESMO). Professor Giuseppe Giaccone, VU medical center, Amsterdam, is the President of this Conference.


'"/>

Contact: Marinus W. Lobbezoo
congress@nddo.org
31-348-442-251
European Society for Medical Oncology
8-Mar-2007


Page: 1

Related biology news :

1. MIT model could predict cells response to drugs
2. New target for HIV/AIDS drugs and vaccine discovered
3. Modified mushrooms may yield human drugs
4. UGR researchers design an alternative to blood test to detect drugs in the body
5. Could fungal collection hold the key to new life-saving drugs?
6. Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway
7. Scientists develop new drugs to fight colon and breast cancer more effectively
8. Anti-inflammatory drugs interact with HRT, and more
9. Generic biologic drugs unlikely to offer significant savings
10. Stem cells provide new tool for studying disease and identifying ALS drugs
11. Enhancing chemotherapys efficacy: New agent has synergistic effect with standard drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2019)... Calif. (PRWEB) , ... March 22, 2019 , ... ... Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary ... NGS market. The five-tube kit is comprised of preformatted master mixes for a ...
(Date:3/18/2019)... , ... March 18, 2019 , ... Periodontal disease, where ... loss, affects nearly 50% of the US population. Making this disease particularly challenging ... biofilm state, where the cells are enmeshed in a sticky extracellular material that makes ...
(Date:3/18/2019)... ... March 18, 2019 , ... ... leader in microbial solutions announce today they have entered into an agreement for ... breakthrough product for biologic nitrogen fixation for corn. This agreement ensures an easy-to-use ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ALISO VIEJO, Calif. (PRWEB) , ... March 19, ... ... subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the formation of their ... dedicated to the advancement of precision medicine that takes into account individual variability ...
(Date:3/15/2019)... PAULO and ATLANTA (PRWEB) , ... ... ... completed the acquisition of 100% equity in American Process Inc. and affiliate ... include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D ...
(Date:3/14/2019)... ... 2019 , ... Murrieta Genomics , the genomic sequencing business incubator, has ... business experience to bear as genomic sequencing startups build their business models. , “We ... that our Advisory Board brings to the table. Many of these experts would be ...
(Date:3/11/2019)... (PRWEB) , ... March 11, 2019 , ... In this ... considered to improve your clinical trial efficiency and experience. Participants will learn how to ... clinical IRT expertise to ensure that the simple or complex randomization scheme is properly ...
Breaking Biology Technology:
Cached News: